Abstract:Introduction Anorexia nervosa (AN) is a severe and chronic psychiatric disorder, resulting from a voluntary food restriction, vomiting, use of laxatives and excessive exercises, leading in dramatic weight loss and high mortality. AN is a multifactorial disease involving genetic and epigenetic factors supporting that AN is a metabo-psychiatric disorder. The molecular mechanisms involved in the etiology of AN remain unclear. One work reported gene expression by RNA sequencing in peripheral blood before and after weight restoration in 6 AN patients (Kim 2013), and one RNA sequencing in human iiPSC-derived neurons from 4 patients and 4 controls (Negraes 2017). To date, the profile of expression of genes and proteins in AN is undetermined. Objectives In this study, our goal is to identify specific gene expression signatures from circulating blood nuclear cells to decipher the pathophysiology of AN and characterize biomarkers that can be used for diagnostic or prognostic of AN. Methods All consented participants are recruited at Sainte-Anne Hospital, Paris, France, using DSM5 criteria. They had a blood draw in Paxgene tube for the collection of RNAs. Total RNA was extracted from peripheral blood mononuclear cells of 15 patients suffering of AN and 15 healthy controls. All messenger RNAs are sequenced on a Novaseq plateform. Reads are aligned to the human genome 19 and statistical analyses on the read counts for differentially expressed genes are computed with DESeq2. Results The total RNA sequencing allows us to identify 673 dysregulates genes (p adjusted value 1,5). Among them, 248 are down-regulated and 425 are up-regulated genes in AN patients compared to controls. From them, 151 transcripts are annotated as pseudogene and 45 are referenced as antisense RNA. Of the 522 remaining transcripts, 424 correspond to a transcript or protein annotated by HGNC and ENSEMBL and 93 are known pseudogenes. A large number of proteins resulting from the expression of deregulated genes interact with each other and form a statistically enriched network impacting biological processes. They are mainly increased and acting in the cellular machinery allowing protein synthesis (biological process: transcription, ribosome, spliceosome and mitochondria). In contrast, down-regulated genes present an enrichment in genes involved in immunity pathways. Finally, several genes are also expressed in the brain. We observed a significant enrichment of genes expressed in the blood and brain tissues. Conclusions We identify specific profiles of gene expression in AN. Several genes are both blood and brain tissue expression. Some genes are good candidates for biomarker of the diagnostic in AN that need to be investigated in a longitudinal study to evaluate their useful as prognostic biomarker of AN. This work is supported by Fondation de France & Fédération Recherche sur le Cerveau. Disclosure of Interest None Declared

MiRNA research—The potential for understanding the multiple facets of anorexia nervosa

Blood Mir-144-3p: a Novel Diagnostic and Therapeutic Tool for Depression

Genetic variants identified in novel candidate genes for anorexia nervosa and analysis of molecular pathways for diagnostic applications

Gene expression of protein synthesis, immunity and brain pathways specifically altered in Anorexia Nervosa

The Utility of Animal Models for Studying the Metabo-Psychiatric Origins of Anorexia Nervosa

Prospective Role of MicroRNAs in Depression

Epigenetic alterations in patients with anorexia nervosa—a systematic review

Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa

Gut Microbiome Changes in Anorexia Nervosa: A Comprehensive Review

The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice

The Impact of Starvation on the Microbiome and Gut-Brain Interaction in Anorexia Nervosa

Mendelian Randomization Analyses Reveal Novel Drug Targets for Anorexia Nervosa

Anorexia Nervosa and Gut Microbiome: Implications for Weight Change and Novel Treatments.

Bridging the gap: Short structural variants in the genetics of anorexia nervosa

miRNA regulation of social and anxiety-related behaviour

Bridging Molecular Discoveries and Therapeutic Potential

The Clinical Potential of Circulating Micrornas in Obesity

A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders

The role of microRNAs in depression

Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests

MICRO-RNA AS DIAGNOSTIC MODALITY OF MAJOR DEPRESSIVE DISORDER